MLTX vs. WOLF
MLTX (MoonLake Immunotherapeutics) and WOLF (Wolfspeed, Inc.) are both stocks. MLTX operates in Biotechnology (Healthcare), while WOLF operates in Semiconductors (Technology). At a 0.22 correlation, their price movements are largely independent.
Performance
MLTX vs. WOLF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MLTX achieves a 36.57% return, which is significantly lower than WOLF's 218.32% return.
MLTX
- 1D
- 0.56%
- 1M
- 5.51%
- YTD
- 36.57%
- 6M
- 19.44%
- 1Y
- -61.60%
- 3Y*
- -14.95%
- 5Y*
- 12.25%
- 10Y*
- —
WOLF
- 1D
- 0.65%
- 1M
- 18.93%
- YTD
- 218.32%
- 6M
- 141.90%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MLTX vs. WOLF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
MLTX MoonLake Immunotherapeutics | 36.57% | 111.05% |
WOLF Wolfspeed, Inc. | 218.32% | -21.22% |
Correlation
The correlation between MLTX and WOLF is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Sep 30, 2025 | 0.22 |
Fundamentals
MLTX:
$1.28B
WOLF:
$21.77B
MLTX:
-$3.90
WOLF:
-$11.53
MLTX:
5.05
WOLF:
21.31
MLTX:
$0.00
WOLF:
$712.50M
MLTX:
-$1.49M
WOLF:
-$208.10M
MLTX:
-$179.84M
WOLF:
-$1.26B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MLTX vs. WOLF — Risk / Return Rank
MLTX
WOLF
MLTX vs. WOLF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and Wolfspeed, Inc. (WOLF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MLTX | WOLF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.18 | — | — |
| Calmar ratioReturn relative to maximum drawdown | -0.69 | — | — |
| Martin ratioReturn relative to average drawdown | -0.98 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MLTX | WOLF | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.53 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 2.34 | -2.22 |
Drawdowns
MLTX vs. WOLF - Drawdown Comparison
The maximum MLTX drawdown since its inception was -90.22%, which is greater than WOLF's maximum drawdown of -58.22%. Use the drawdown chart below to compare losses from any high point for MLTX and WOLF.
Loading charts...
Drawdown Indicators
| MLTX | WOLF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.22% | -58.22% | -32.00% |
Max Drawdown (1Y)Largest decline over 1 year | -89.93% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -90.22% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -90.22% | — | — |
Current DrawdownCurrent decline from peak | -71.81% | -24.60% | -47.21% |
Average DrawdownAverage peak-to-trough decline | -29.24% | -34.87% | +5.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 63.21% | — | — |
Volatility
MLTX vs. WOLF - Volatility Comparison
Loading charts...
Volatility by Period
| MLTX | WOLF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.65% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 55.24% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 115.84% | 120.69% | -4.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.15% | 120.69% | -29.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.45% | 120.69% | -34.24% |
Dividends
MLTX vs. WOLF - Dividend Comparison
Neither MLTX nor WOLF has paid dividends to shareholders.
Financials
MLTX vs. WOLF - Financials Comparison
This section allows you to compare key financial metrics between MoonLake Immunotherapeutics and Wolfspeed, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MLTX and WOLF have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for MLTX and WOLF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer